This company has been marked as potentially delisted and may not be actively trading. Bellicum Pharmaceuticals (BLCM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BLCM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Bellicum Pharmaceuticals Inc (BLCM)April 16, 2025 | uk.investing.comBellicum Pharmaceuticals Inc (OTC:BLCM) Stock Quotes, Forecast and News SummaryOctober 14, 2024 | benzinga.comBellicum sells assets to MD Anderson, moves towards liquidationFebruary 22, 2024 | msn.comBellicum Pharmaceuticals Issues Super-Voting Share PrivatelyJanuary 25, 2024 | msn.comBellicum Pharmaceuticals Inc BLCMDecember 23, 2023 | morningstar.comMBellicum Pharmaceuticals Stock (OTC:BLCM), Short Interest ReportDecember 8, 2023 | benzinga.comFutura Medical plc (FAMDF)October 26, 2023 | finance.yahoo.comBLCM - Bellicum Pharmaceuticals, Inc.July 13, 2023 | finance.yahoo.comBellicum Pharmaceuticals (NASDAQ: BLCM)June 3, 2023 | fool.comBellicum Pharmaceuticals (Nasdaq:BLCM) HeadlineTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | marketbeat.comBellicum Pharmaceuticals (Nasdaq:BLCM) HeadlineTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | marketbeat.comWhy Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?May 8, 2023 | investorplace.comWhy Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving PremarketApril 18, 2023 | msn.comShort Volatility Alert: Bellicum PharmaApril 18, 2023 | benzinga.comBLCM Plummets on Stopping Trials of BPX-601 and BPX-603March 15, 2023 | msn.comWhy Bellicum Pharmaceuticals (BLCM) Stock Is Down 48%March 15, 2023 | msn.comBellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesMarch 14, 2023 | finance.yahoo.comBellicum Pharmaceuticals (Nasdaq:BLCM) HeadlineTrading was temporarily halted for "BLCM" at 04:03 PM with a stated reason of "News pending."...March 14, 2023 | marketbeat.comWhy Bellicum Pharmaceuticals Stock Is Plunging TodayFebruary 24, 2023 | finance.yahoo.comBellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumFebruary 16, 2023 | finance.yahoo.comCORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 31, 2023 | finance.yahoo.comBellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers SymposiumJanuary 19, 2023 | finance.yahoo.comBellicum Pharmaceuticals (Nasdaq:BLCM) HeadlineTrading was temporarily halted for "BLCM" at 02:01 PM with a stated reason of "LULD pause."...January 6, 2023 | marketbeat.comBellicum Pharmaceuticals, Inc.: Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNovember 13, 2022 | finanznachrichten.deBellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNovember 10, 2022 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the MesaOctober 4, 2022 | finance.yahoo.comBLCM Bellicum Pharmaceuticals, Inc.September 15, 2022 | seekingalpha.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 1, 2022 | finance.yahoo.comBellicum Pharmaceuticals (BLCM) Could Find Support Soon, Here's Why You Should Buy the Stock NowAugust 25, 2022 | finance.yahoo.comIs Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?August 18, 2022 | finance.yahoo.comBellicum Reports Second Quarter 2022 Financial Results and Provides Operational UpdateAugust 11, 2022 | finance.yahoo.comBellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42May 13, 2022 | seekingalpha.comBellicum Reports First Quarter 2022 Financial Results and Provides Operational UpdateMay 13, 2022 | finance.yahoo.comBellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational UpdateMarch 24, 2022 | finance.yahoo.comLadenburg Thalmann Initiates Coverage On Bellicum Pharmaceuticals with Buy Rating, Announces Price Target of $5February 16, 2022 | benzinga.comBellicum Pharmaceuticals Inc. BLCMJanuary 28, 2022 | stockhouse.comBellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology ConferenceJanuary 26, 2022 | finance.yahoo.comBellicum Regains Compliance with Nasdaq Continued Listing RequirementsDecember 13, 2021 | finance.yahoo.comSumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021December 10, 2021 | finance.yahoo.comBellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer StudiesDecember 7, 2021 | msn.comBellicum Reports Positive Interim Data From Phase 1/2 GoCAR-T Trials - Quick FactsDecember 6, 2021 | markets.businessinsider.comBellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at MarketDecember 6, 2021 | finance.yahoo.comK2 BioLabs hiring, expanding contract research offerings for biotech, pharma startupsDecember 2, 2021 | bizjournals.comBellicum Reports Third Quarter 2021 Financial Results and Provides Operational UpdateNovember 4, 2021 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ...September 3, 2021 | apnews.comABellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 3, 2021 | finance.yahoo.comBellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety SwitchSeptember 1, 2021 | finance.yahoo.comBellicum Pharmaceuticals: Q2 Earnings SnapshotAugust 12, 2021 | sfgate.comBellicum Reports Second Quarter 2021 Financial Results and Provides Operational UpdateAugust 12, 2021 | finance.yahoo.com Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLCM Media Mentions By Week BLCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCM News Sentiment▼0.340.72▲Average Medical News Sentiment BLCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCM Articles This Week▼00▲BLCM Articles Average Week Get the Latest News and Ratings for BLCM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bellicum Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Jasper Therapeutics News Today NewAmsterdam Pharma News Today Nutriband News Today Reviva Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLCM) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellicum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
